Skip Navigation

Cardiovascular Research 2007 73(1):1-2; doi:10.1016/j.cardiores.2006.11.002
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knowlton, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knowlton, A. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Life, death, the unfolded protein response and apoptosis

Anne A. Knowlton*

Molecular and Cellular Cardiology, Cardiovascular Division, University of California, One Shields Avenue, Davis, CA 95616, Davis, CA, United States
Sacramento VA Medical Center, Sacramento, CA, United States

* Molecular and Cellular Cardiology, Cardiovascular Division, University of California, One Shields Avenue, Davis, CA 95616, Davis, CA, United States. Tel.: +1 530 752 5461; fax: +1 530 754 7167. Email address: aaknowlton{at}ucdavis.edu

Received 30 October 2006; accepted 1 November 2006

See article by Nickson et al. [1] (pages 48–56) in this issue.

The unfolded protein response (UPR) occurs in cells in response to accumulation of unfolded proteins in the endoplasmic reticulum (ER). When unfolded protein accumulates secondary to a mild stress, universal protein synthesis is inhibited, but then resumes upon recovery. In contrast, a more severe or persistent stress would lead to apoptosis. UPR has not been extensively studied in the heart, though it has been described recently in association with some disease states such as hypertrophy and ischemia. In the current issue, Nickson et al. report the role of p53-upregulated modulator of apoptosis (PUMA) in the apoptotic response to UPR in neonatal rat cardiac myocytes [1].

Nickson et al. found that UPR induced by either tunicamycin, which blocks glycosylation, or by thapsigargin, which reduces ER calcium, upregulated expression of PUMA beginning at 8 h for mRNA with marked increase in PUMA protein observed at 12 h, and returned to normal by 48 h in isolated rat neonatal cardiomyocytes [1]. Induction of the UPR resulted in apoptosis, which was manifest by 24 h and maximal by 48 h, with 40 to 70% of cells being apoptotic. Using an adenoviral shRNA, the authors blocked PUMA induction and greatly inhibited apoptosis. In a second approach, isolated mouse neonatal cardiomyocytes were prepared from wild-type, PUMA +/–, and PUMA –/– mice. Thapsigargin treatment induced apoptosis in the wild-type and PUMA heterozygotes, while the PUMA knockout mice were resistant to apoptosis, as measured by caspase-3 cleavage. Thus, PUMA has an important role in UPR-associated apoptosis in cardiac myocytes.


    1. UPR
 Top
 1. UPR
 2. PUMA and apoptosis
 Acknowledgments
 References
 
There have been a number of excellent, recent, in-depth reviews on UPR [2–4]. The accumulation of unfolded proteins in the ER triggers UPR. Under normal conditions, GRP78 (also known as BiP), which is a heat-shock protein resident in the ER, binds and blocks three sensor proteins present in the ER membrane (Fig. 1). When unfolded protein accumulates in the ER lumen, GRP78 shifts from blocking the sensor proteins to binding the unfolded proteins, triggering UPR. The three sensor proteins PERK, IRE1{alpha} and ATF6, once activated, lead to inhibition of translation and increased transcription of chaperones, stress response genes, and redox-related genes. Despite phosphorylation of eIF2 after activation of PERK, certain mRNA, particularly coding for chaperones, can still be translated. Initially, the UPR response triggers a pause in new protein synthesis. This can allow time for recovery with synthesis of more chaperones for folding of proteins in the ER. If UPR persists, then a second phase is entered, triggering apoptosis. The impact of the UPR is evident in the Akita mouse, a relatively new model of diabetes. The Akita mouse has a mutation converting one of the cysteines needed for the three cysteine–cysteine double bonds in insulin to tyrosine. As a result, proinsulin cannot be processed to its final form and accumulates in the ER, resulting in a sustained UPR [5,6]. The sustained UPR leads to apoptosis and loss of the β cells of the Islets, resulting in type I diabetes.


Figure 1
View larger version (29K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1 This diagram summarizes the major events involved in the UPR. In the unstressed ER, PERK, IRE1{alpha}, and ATF6 are all blocked by the binding of luminal GRP78. Stress, characterized by the accumulation of unfolded proteins in the ER lumen, causes GRP78 to dissociate from the three sensor proteins (PERK, IRE1{alpha}, and ATF6) and to bind to the unfolded proteins. Dissociation of GRP78 activates the three sensors, leading to a cascade of changes as shown on the right. The induction of the UPR does not always lead to apoptosis, but can instead be stopped with the reversal of the accumulation of unfolded protein in the lumen. Once the accumulation of unfolded protein is corrected, normal protein synthesis can resume, and apoptosis is averted.

 
A number of inherited diseases have been linked to abnormalities in the response to ER stress [2]. Several of these cause diabetes, but other diseases associated with ER stress include Parkinson's, familial Alzheimer's, and amyotrophic lateral sclerosis. One would expect that ER stress would be a factor in cardiomyopathy, although few studies have addressed this issue. Mutation of KDEL, a retrieval receptor for luminal chaperones (such as GRP78), caused a dilated cardiomyopathy [7]. Aortic banding has been found to increase expression of GRP78, and this was blocked by angiotensin II inhibitors [8]. Ischemia/reperfusion in the mouse heart was shown to upregulate GRP78 and GRP94, both of which are ER chaperones [9]. As shown in Fig. 1, ATF6, once activated, increases expression of GRP78 and GRP94. In a model with tamoxifen induction of the active form of ATF6, GRP78 and GRP94 had markedly increased expression, and there was less necrosis and apoptosis after ischemia/reperfusion. Thus, in a limited number of studies, UPR and ER stress have been found to have important roles in cardiomyopathy and ischemic injury.


    2. PUMA and apoptosis
 Top
 1. UPR
 2. PUMA and apoptosis
 Acknowledgments
 References
 
PUMA is a BH3-only, pro-apoptotic protein, and there have been several excellent reviews on PUMA and BH3 proteins recently [10,11]. When activated, BH3 proteins bind Bcl-2-like proteins and block their anti-apoptotic function. PUMA binds all the pro-survival proteins, Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and A1 [11]. As Nickson et al. demonstrate, PUMA has an important role in UPR-related apoptosis in the neonatal cardiac myocyte [1]. Blocking expression of PUMA greatly reduced apoptosis after induction of the UPR. Similarly, knockout of PUMA also inhibited apoptosis after induction of the UPR. Although Nickson et al.'s results would suggest that PUMA is the lynchpin for UPR-related apoptosis in the cardiac myocyte, further work will be needed to evaluate the role of PUMA vs. other pro-apoptotic factors in cell death after induction of the UPR.


    Acknowledgments
 Top
 1. UPR
 2. PUMA and apoptosis
 Acknowledgments
 References
 
Supported by HL077281, HL079071, AG19327, and a Merit Award from the Department of Veterans Affairs.


    References
 Top
 1. UPR
 2. PUMA and apoptosis
 Acknowledgments
 References
 

  1. Nickson P., Toth A., Erhardt P. PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res (2007) 73:48–56. 10.1016/j.cardiores.2006.10.001.[Abstract/Free Full Text]
  2. Zhao L., Ackerman S.L. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol (2006) 18:444–452.[CrossRef][Web of Science][Medline]
  3. Szegezdi E., Logue S.E., Gorman A.M., Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep (2006) 7:880–885.[CrossRef][Web of Science][Medline]
  4. Marciniak S.J., Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev (2006) 86:1133–1149.[Abstract/Free Full Text]
  5. Oyadomari S., Koizumi A., Takeda A., Gotoh T., Akira S., Araki E., et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest (2002) 109:525–532.[CrossRef][Web of Science][Medline]
  6. Ron D. Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. J Clin Invest (2002) 109:443–445.[CrossRef][Web of Science][Medline]
  7. Hamada H., Suzuki M., Yuasa S., Mimura N., Shinozuka N., Takada Y., et al. Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice. Mol Cell Biol (2004) 24:8007–8017.[Abstract/Free Full Text]
  8. Okada K., Minamino T., Tsukamoto Y., Liao Y., Tsukamoto O., Takashima S., et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation (2004) 110:705–712.[Abstract/Free Full Text]
  9. Martindale J.J., Fernandez R., Thuerauf D., Whittaker R., Gude N., Sussman M.A., et al. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res (2006) 98:1186–1193.[Abstract/Free Full Text]
  10. Webster K.A., Graham R.M., Thompson J.W., Spiga M., Frazier D.P., Wilson A., et al. Redox stress and the contributions of BH3-only proteins to infarction. Antioxid Redox Signal (2006) 8:1667–1676.[CrossRef][Web of Science][Medline]
  11. Willis S.N., Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol (2005) 17:617–625.[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knowlton, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knowlton, A. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?